tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market
Advertisement

KalVista Pharmaceuticals (KALV) Income Statement

Compare
511 Followers

KalVista Pharmaceuticals Income Statement

Last quarter (Q4 2025), KalVista Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, KalVista Pharmaceuticals's net income was $-52.22M. See KalVista Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 12.69M
Gross Profit
$ 0.00$ -86.17M$ -802.00K$ -743.00K$ 12.04M
Operating Expenses
$ 188.00M$ 54.28M$ 110.87M$ 96.61M$ 57.92M
Depreciation and Amortization
$ 941.00K$ 816.00K$ 802.00K$ 743.00K$ 651.00K
EBITDA
$ -173.33M$ -134.28M$ -92.11M$ -81.60M$ -45.59M
Operating Income
$ -188.00M$ -140.44M$ -110.87M$ -96.61M$ -57.92M
Other Income/Expenses
$ 7.94M$ 5.35M$ 17.96M$ 14.27M$ 11.68M
Pretax Income
$ -180.05M$ -135.10M$ -92.91M$ -82.34M$ -46.24M
Net Income
$ -183.44M$ -126.64M$ -74.85M$ -68.51M$ -44.49M
Per Share Metrics
Basic EPS
$ -3.69$ -3.44$ -2.68$ -2.80$ -2.33
Diluted EPS
$ -3.69$ -3.44$ -2.68$ -2.80$ -2.33
Weighted Average Shares Outstanding
49.65M 36.79M 27.89M 24.47M 19.09M
Weighted Average Shares Outstanding (Diluted)
49.65M 36.79M 27.89M 24.47M 19.09M
Currency in USD

KalVista Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis